Opinion · 29 Dec 2025
EditorialPublished 22 Oct 2016
Caffeine Consumption with Relevance to Type 3 Diabetes and Accelerated Brain Aging
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Keywords Caffeine, diabetes, Sirtuin 1 Editorial The main constituent of plaques in the brain of Alzheimer’s disease (AD) individuals namely amyloid beta (Aβ) [1] is a proteolytic product of a larger protein, the amyloid precursor protein (APP) protein. Carriers of the apo E4 allele are at greater risk of developing AD with increased deposition of amyloid beta plaques in Western countries. Apo E4 is also a major risk factor for cardiovascular disease linked to defective cholesterol metabolism [2,3]. Protein and Aβ homeostasis is now crucial to the lifespan of organisms and is an important feature that determines the aging process in obesity, diabetes and neurodegenerative diseases [4]. The scientific understanding of the maintenance of peripheral blood plasma Aβ metabolism has now become essential to prevent neurodegeneration and is now linked to Type 3 diabetes [5,6]. The concentration of Aβ within the brain is determined by hepatic Aβ clearance and interest in the liver has increased markedly since in Western countries the incidence of non-alcoholic fatty liver disease (NAFLD) has reached approx. 20% of the developed world and by the year 2050 it may reach to approx. 40% of the global population [7]. Induction of Type 3 diabetes disease progression now involves unhealthy diets that corrupts neuron calcium flux and the circadian rhythm of the neuron Aβ peptide [8-13] connected to defective peripheral hepatic glucose and Aβ metabolism [4] in individuals with NAFLD [4]. The liver is of principal importance and the mechanisms for the clearance of Aβ by the liver involve lipoproteins (5%) and albumin (90%) which bind and sequester Aβ for clearance to the liver, preventing the toxic effects of Aβ to the heart and brain [4]. Caffeine is hydrophobic and increased consumption can rapidly allow distribution to the liver and adipose tissue with rapid transport across the blood brain barrier to neurons [14-17]. In adipose tissue caffeine has been shown to increase adinopectin levels with relevance to anti-aging gene activation [18-20] and the adipose tissue-liver crosstalk [21]. Caffeine has become important to peripheral Aβ metabolism with suppression of plasma and brain Aβ in AD transgenic mice [22,] and beneficial effects involve prevention of bacterial lipopolysaccharides (LPS) induction of inflammation and Aβ aggregation [24,25]. In the developing world increased plasma LPS levels may override caffeine effects with spontaneous Aβ aggregation [26,27]. Caffeine consumption over many years’ effects cerebrospinal fluid production (CSF) and increased caffeine binding to albumin may displace Aβ from CSF albumin and mediate toxic effects on Aβ oligomer generation relevant to the development of Type 3 diabetes and various neurological diseases [28-31]. In global NAFLD epidemic caffeine metabolism is markedly reduced and metabolism of caffeine (4-6 hr) delayed (Figure 1) with increased transport of caffeine to the brain with effects on altered neuron calcium signalling relevant to the induction of Type 3 diabetes and circadian rhythm abnormalities [14-16,32-36]. Caffeine is metabolized mostly by the P450 enzyme system in the body and specifically the CYP1A enzymes (CYP1A1, 1A2) [37,38]. The metabolism by hepatic CYP1A enzymes of caffeine follows first-order kinetics and is the rate-limiting step of plasma clearance [37,38]. Interest in the anti-aging gene Sirtuin 1 (Sirt 1) in neuron transcriptional responses has accelerated with relevance to Type 3 diabetes [5,6] and the gene Sirt 1 is now connected to the development of NAFLD [39,40] with its deacetylation of nuclear pregnane X receptor (PXR) relevant to drug metabolism [39]. Sirt 1/PXR interactions are now important to the regulation of the CYP1A enzymes [37,38] with rapid metabolism of caffeine in individuals without NAFLD. Caffeine consumption (coffee, coca cola, chocolate, tea, other sources) that was previously recommended to be approx. 200 mg Figure 1: In panel A hepatic caffeine metabolism is rapid with a half-life between 4-6 hrs. Caffeine reduce LPS inflammatory effect with reduced LPS transport to the brain that allows efficient circadian rhythm circuitry with rapid brain amyloid beta transport to the liver. In panel B the global NAFLD epidemic indicates that caffeine consumption should be carefully modified to reduce excessive caffeine transport to the brain that induces Type 3 diabetes by interference with magnesium/Sirt 1 activation responsible for neuron proliferation and normal brain glucose and amyloid beta metabolism.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Research & Reviews: Neuroscience.
Review article · 29 Dec 2025
Psychiatric Neuroscience: Bridging Brain Function and Mental Disorders
Perspective · 29 Dec 2025
Psychiatric Neurobiology: Bridging Brain Circuits, Molecular Pathways, and the Future of Mental Health Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch & Reviews: Neuroscience
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Martins IJ”